Cluster of Differentiation 44 (CD44) is a cell surface glycoprotein that is a recognized marker for cancer stem cells (CSC), a subpopulation of tumor cells that is capable of self-renewal and is associated with carcinogenesis, tumor progression, metastatic spread, and resistance to chemotherapy and radiation therapy [162]. The gene discussed is CD44; the disease is cancer.